Quality of life and pain in patients with metastatic bone disease from solid tumors treated with bone-targeted agents – a real-world cross-sectional study from Switzerland (SAKK 95/16)

Bone-targeted agents (BTAs) are widely used in the management of patients with bone metastases from solid tumors. Knowledge of the impact of their routine care use on patient-reported pain and bone pain-relate...

Source: BMC Cancer - February 19, 2021 Category: Cancer & Oncology Authors: Karin Ribi, Beat Th ürlimann, Corinne Schär, Daniel Dietrich, Richard Cathomas, Ursina Zürrer-Härdi, Thomas von Briel, Sandro Anchisi, Pierre Bohanes, Veronika Blum, Philippe von Burg, Meinrad Mannhart, Clemens B. Caspar, Roger von Moos and Michael Ma Tags: Research article Source Type: research